GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Keyuan Pharmaceutical Co Ltd (SZSE:301281) » Definitions » Capital Expenditure

Shandong Keyuan Pharmaceutical Co (SZSE:301281) Capital Expenditure : ¥-246.13 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Shandong Keyuan Pharmaceutical Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Shandong Keyuan Pharmaceutical Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was ¥-36.4 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-246.13 Mil.

Shandong Keyuan Pharmaceutical Co Capital Expenditure Historical Data

The historical data trend for Shandong Keyuan Pharmaceutical Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Keyuan Pharmaceutical Co Capital Expenditure Chart

Shandong Keyuan Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.13 -20.20 -31.11 -70.15 -296.38

Shandong Keyuan Pharmaceutical Co Quarterly Data
Jun18 Dec18 Jun19 Dec19 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -86.65 -76.82 -50.63 -82.29 -36.39

Shandong Keyuan Pharmaceutical Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-246.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Keyuan Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Keyuan Pharmaceutical Co Ltd (SZSE:301281) » Definitions » Capital Expenditure
Comparable Companies
SZSE:001367 SZSE:300006 SZSE:301096 SZSE:002198 SHSE:600613 SHSE:688710 SZSE:000908 SZSE:000705 SZSE:301507 SZSE:000952 LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN MRK AMGN GILD
Traded in Other Exchanges
N/A
Address
Keyuan Street, Shandong Shanghe Economic Development Zone, Shandong Province, Jinan, CHN, 251601
Website
http://www.keyuanpharm.com
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and their preparations.

Shandong Keyuan Pharmaceutical Co Headlines

No Headlines